Sumitomo Mitsui Financial Group, Inc. Biogen Inc. Transaction History

Sumitomo Mitsui Financial Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$194.69 - $268.46 $33,097 - $45,638	170 New	170 $45,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $149,316 - $224,758	-632 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $167,334 - $193,208	632 New	632 $179,000

990

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Financial Group, Inc. with notifications on news.